These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
925 related articles for article (PubMed ID: 27233483)
1. The Philadelphia chromosome in leukemogenesis. Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483 [TBL] [Abstract][Full Text] [Related]
2. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Drexler HG; MacLeod RA; Uphoff CC Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072 [TBL] [Abstract][Full Text] [Related]
3. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series. Bayrak AG; Daglar Aday A; Yavuz AS; Nalcaci M; Ozbalak MM; Cefle K; Ozturk S; Palanduz S Leuk Res; 2021 Dec; 111():106725. PubMed ID: 34634595 [TBL] [Abstract][Full Text] [Related]
4. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076 [TBL] [Abstract][Full Text] [Related]
5. Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia. Pavlovsky C; Chan O; Talati C; Pinilla-Ibarz J Future Oncol; 2019 Jan; 15(3):257-269. PubMed ID: 30251548 [TBL] [Abstract][Full Text] [Related]
6. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review. Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459 [TBL] [Abstract][Full Text] [Related]
8. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone. Winter SS; Greene JM; McConnell TS; Willman CL Leukemia; 1999 Dec; 13(12):2007-11. PubMed ID: 10602422 [TBL] [Abstract][Full Text] [Related]
9. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Steinberg M Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072 [TBL] [Abstract][Full Text] [Related]
10. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia. Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580 [TBL] [Abstract][Full Text] [Related]
11. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973 [TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia: molecular and cellular aspects. Pasternak G; Hochhaus A; Schultheis B; Hehlmann R J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825 [TBL] [Abstract][Full Text] [Related]
14. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia. Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463 [TBL] [Abstract][Full Text] [Related]
15. SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122 [TBL] [Abstract][Full Text] [Related]
16. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation. Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732 [TBL] [Abstract][Full Text] [Related]
17. Chromosome abnormalities in CML. Hagemeijer A Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858 [TBL] [Abstract][Full Text] [Related]
18. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias. Burmeister T; Gröger D; Kühn A; Hoelzer D; Thiel E; Reinhardt R DNA Repair (Amst); 2011 Nov; 10(11):1131-7. PubMed ID: 21944569 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia. Zhang Z; Chen Z; Jiang M; Liu S; Guo Y; Wan L; Li F BMC Cancer; 2019 Oct; 19(1):935. PubMed ID: 31594548 [TBL] [Abstract][Full Text] [Related]